Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study-Reference-Cited by-同舟云学术

Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study

Published:2012-09 Issue:3 Volume:126 Page:341-345
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Takekuma Munetaka,Hirashima Yasuyuki,Ito Kimihiko,Tsubamoto Hiroshi,Tabata Tsutomu,Arakawa Atsushi,Itani Yoshio,Furukawa Naoto,Murakoshi Homare,Takeuchi Satoshi

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference20 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study;Bonomi;J Clin Oncol,1985

3. Phase II trial of ifosfamide and mensa in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study;Sutton;Am J Obstet Gynecol,1993

4. Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group study;McGuire;J Clin Oncol,1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer;Journal of Cancer Research and Clinical Oncology;2024-06-25

2. A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy;World Journal of Surgical Oncology;2023-07-21

3. Nedaplatin use in patients with hypersensitivity reaction episodes to carboplatin;Taiwanese Journal of Obstetrics and Gynecology;2020-07

4. Advances in paclitaxel combinations for treating cervical cancer;Expert Opinion on Pharmacotherapy;2020-02-08

5. Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer;International Journal of Clinical Oncology;2018-10-05